The effectiveness and safety of a planned investment procedure in high-risk chronic total occlusions - The INVEST CTO single arm study
Kalaivani Mahadevan and Sofia Papadopoulou provide their take on the INVEST CTO trial, presented by Anja Oksnes at TCT 2025, in San Francisco.
